The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare

David Peiris, Tim Usherwood, Katie Panaretto, Mark Harris, Jenny Hunt, Bindu Patel, Nicholas Zwar, Julie Redfern, Stephen MacMahon, Stephen Colagiuri, Noel Hayman, Anushka Patel

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)

Abstract

Background: Large gaps exist in the implementation of guideline recommendations for cardiovascular disease (CVD) risk management. Electronic decision support (EDS) systems are promising interventions to close these gaps but few have undergone clinical trial evaluation in Australia. We have developed HealthTracker, a multifaceted EDS and quality improvement intervention to improve the management of CVD risk. Methods/design: It is hypothesised that the use of HealthTracker over a 12-month period will result in: (1) an increased proportion of patients receiving guideline-indicated measurements of CVD risk factors and (2) an increased proportion of patients at high risk will receive guideline-indicated prescriptions for lowering their CVD risk. Sixty health services (40 general practices and 20 Aboriginal Community Controlled Health Services (ACCHSs) will be randomised in a 1:1 allocation to receive either the intervention package or continue with usual care, stratified by service type, size and participation in existing quality improvement initiatives. The intervention consists of point-of-care decision support; a risk communication interface; a clinical audit tool to assess performance on CVD-related indicators; a quality improvement component comprising peer-ranked data feedback and support to develop strategies to improve performance. The control arm will continue with usual care without access to these intervention components. Quantitative data will be derived from cross-sectional samples at baseline and end of study via automated data extraction. Detailed process and economic evaluations will also be conducted. Ethics and dissemination: The general practice component of the study is approved by the University of Sydney Human Research Ethics Committee (HREC) and the ACCHS component is approved by the Aboriginal Health and Medical Research Council HREC. Formal agreements with each of the participating sites have been signed. In addition to the usual scientific forums, results will be disseminated via newsletters, study websites, face-to-face feedback forums and workshops. Trial registration: The trial is registered with the Australian Clinical Trials Registry ACTRN 12611000478910.

Original languageEnglish
Article numbere002177
JournalBMJ Open
Volume2
Issue number6
DOIs
Publication statusPublished - 19 Dec 2012
Externally publishedYes

Fingerprint

Quality Improvement
Primary Health Care
Cardiovascular Diseases
Randomized Controlled Trials
Community Health Services
Research Ethics Committees
Guidelines
General Practice
Point-of-Care Systems
Clinical Trials
Clinical Audit
Therapeutics
Risk Management
Disease Management
Ethics
Health Services
Cost-Benefit Analysis
Prescriptions
Registries
Biomedical Research

Cite this

Peiris, David ; Usherwood, Tim ; Panaretto, Katie ; Harris, Mark ; Hunt, Jenny ; Patel, Bindu ; Zwar, Nicholas ; Redfern, Julie ; MacMahon, Stephen ; Colagiuri, Stephen ; Hayman, Noel ; Patel, Anushka. / The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study : Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. In: BMJ Open. 2012 ; Vol. 2, No. 6.
@article{e44d2d6b338c47ff987c6af90cf47355,
title = "The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare",
abstract = "Background: Large gaps exist in the implementation of guideline recommendations for cardiovascular disease (CVD) risk management. Electronic decision support (EDS) systems are promising interventions to close these gaps but few have undergone clinical trial evaluation in Australia. We have developed HealthTracker, a multifaceted EDS and quality improvement intervention to improve the management of CVD risk. Methods/design: It is hypothesised that the use of HealthTracker over a 12-month period will result in: (1) an increased proportion of patients receiving guideline-indicated measurements of CVD risk factors and (2) an increased proportion of patients at high risk will receive guideline-indicated prescriptions for lowering their CVD risk. Sixty health services (40 general practices and 20 Aboriginal Community Controlled Health Services (ACCHSs) will be randomised in a 1:1 allocation to receive either the intervention package or continue with usual care, stratified by service type, size and participation in existing quality improvement initiatives. The intervention consists of point-of-care decision support; a risk communication interface; a clinical audit tool to assess performance on CVD-related indicators; a quality improvement component comprising peer-ranked data feedback and support to develop strategies to improve performance. The control arm will continue with usual care without access to these intervention components. Quantitative data will be derived from cross-sectional samples at baseline and end of study via automated data extraction. Detailed process and economic evaluations will also be conducted. Ethics and dissemination: The general practice component of the study is approved by the University of Sydney Human Research Ethics Committee (HREC) and the ACCHS component is approved by the Aboriginal Health and Medical Research Council HREC. Formal agreements with each of the participating sites have been signed. In addition to the usual scientific forums, results will be disseminated via newsletters, study websites, face-to-face feedback forums and workshops. Trial registration: The trial is registered with the Australian Clinical Trials Registry ACTRN 12611000478910.",
author = "David Peiris and Tim Usherwood and Katie Panaretto and Mark Harris and Jenny Hunt and Bindu Patel and Nicholas Zwar and Julie Redfern and Stephen MacMahon and Stephen Colagiuri and Noel Hayman and Anushka Patel",
year = "2012",
month = "12",
day = "19",
doi = "10.1136/bmjopen-2012-002177",
language = "English",
volume = "2",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "6",

}

The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study : Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. / Peiris, David; Usherwood, Tim; Panaretto, Katie; Harris, Mark; Hunt, Jenny; Patel, Bindu; Zwar, Nicholas; Redfern, Julie; MacMahon, Stephen; Colagiuri, Stephen; Hayman, Noel; Patel, Anushka.

In: BMJ Open, Vol. 2, No. 6, e002177, 19.12.2012.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study

T2 - Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare

AU - Peiris, David

AU - Usherwood, Tim

AU - Panaretto, Katie

AU - Harris, Mark

AU - Hunt, Jenny

AU - Patel, Bindu

AU - Zwar, Nicholas

AU - Redfern, Julie

AU - MacMahon, Stephen

AU - Colagiuri, Stephen

AU - Hayman, Noel

AU - Patel, Anushka

PY - 2012/12/19

Y1 - 2012/12/19

N2 - Background: Large gaps exist in the implementation of guideline recommendations for cardiovascular disease (CVD) risk management. Electronic decision support (EDS) systems are promising interventions to close these gaps but few have undergone clinical trial evaluation in Australia. We have developed HealthTracker, a multifaceted EDS and quality improvement intervention to improve the management of CVD risk. Methods/design: It is hypothesised that the use of HealthTracker over a 12-month period will result in: (1) an increased proportion of patients receiving guideline-indicated measurements of CVD risk factors and (2) an increased proportion of patients at high risk will receive guideline-indicated prescriptions for lowering their CVD risk. Sixty health services (40 general practices and 20 Aboriginal Community Controlled Health Services (ACCHSs) will be randomised in a 1:1 allocation to receive either the intervention package or continue with usual care, stratified by service type, size and participation in existing quality improvement initiatives. The intervention consists of point-of-care decision support; a risk communication interface; a clinical audit tool to assess performance on CVD-related indicators; a quality improvement component comprising peer-ranked data feedback and support to develop strategies to improve performance. The control arm will continue with usual care without access to these intervention components. Quantitative data will be derived from cross-sectional samples at baseline and end of study via automated data extraction. Detailed process and economic evaluations will also be conducted. Ethics and dissemination: The general practice component of the study is approved by the University of Sydney Human Research Ethics Committee (HREC) and the ACCHS component is approved by the Aboriginal Health and Medical Research Council HREC. Formal agreements with each of the participating sites have been signed. In addition to the usual scientific forums, results will be disseminated via newsletters, study websites, face-to-face feedback forums and workshops. Trial registration: The trial is registered with the Australian Clinical Trials Registry ACTRN 12611000478910.

AB - Background: Large gaps exist in the implementation of guideline recommendations for cardiovascular disease (CVD) risk management. Electronic decision support (EDS) systems are promising interventions to close these gaps but few have undergone clinical trial evaluation in Australia. We have developed HealthTracker, a multifaceted EDS and quality improvement intervention to improve the management of CVD risk. Methods/design: It is hypothesised that the use of HealthTracker over a 12-month period will result in: (1) an increased proportion of patients receiving guideline-indicated measurements of CVD risk factors and (2) an increased proportion of patients at high risk will receive guideline-indicated prescriptions for lowering their CVD risk. Sixty health services (40 general practices and 20 Aboriginal Community Controlled Health Services (ACCHSs) will be randomised in a 1:1 allocation to receive either the intervention package or continue with usual care, stratified by service type, size and participation in existing quality improvement initiatives. The intervention consists of point-of-care decision support; a risk communication interface; a clinical audit tool to assess performance on CVD-related indicators; a quality improvement component comprising peer-ranked data feedback and support to develop strategies to improve performance. The control arm will continue with usual care without access to these intervention components. Quantitative data will be derived from cross-sectional samples at baseline and end of study via automated data extraction. Detailed process and economic evaluations will also be conducted. Ethics and dissemination: The general practice component of the study is approved by the University of Sydney Human Research Ethics Committee (HREC) and the ACCHS component is approved by the Aboriginal Health and Medical Research Council HREC. Formal agreements with each of the participating sites have been signed. In addition to the usual scientific forums, results will be disseminated via newsletters, study websites, face-to-face feedback forums and workshops. Trial registration: The trial is registered with the Australian Clinical Trials Registry ACTRN 12611000478910.

UR - http://www.scopus.com/inward/record.url?scp=84871103369&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2012-002177

DO - 10.1136/bmjopen-2012-002177

M3 - Article

VL - 2

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 6

M1 - e002177

ER -